ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

An Individualized Risk Calculator for Research in Prodromal Psychosis

Cannon Tyrone D*; Yu Changhong; Addington Jean; Bearden Carrie E; Cadenhead Kristin S; Cornblatt Barbara A; Heinssen Robert; Jeffries Clark D; Mathalon Daniel H; McGlashan Thomas H; Perkins Diana O; Seidman Larry J; Tsuang Ming T; Walker Elaine F; Woods Scott W; Kattan Michael W2; 1; new
AMERICAN JOURNAL OF PSYCHIATRY2016-10DOI: 10.1176/appi.ajp.2016.15070890
5被引4阅读
引用收藏
分享

摘要

Objective: Approximately 20%-35% of individuals 12-35 years old who meet criteria for a prodromal risk syndrome convert to psychosis within 2 years. However, this estimate ignores the fact that clinical high-risk cases vary considerably in risk. The authors sought to create a risk calculator, based on profiles of risk indicators, that can ascertain the probability of conversion to psychosis in individual patients. <br>Method: The study subjects were 596 clinical high-risk participants from the second phase of the North American Prodrome Longitudinal Study who were followed lip to the time of conversion to psychosis or last contact (up to 2 years). The predictors examined were limited to those that are supported by previous studies and are readily obtainable in general clinical settings. Time-to-event regression was used to build a multivariate model predicting conversion, with internal validation using 1,000 bootstrap resamples. <br>Results: The 2-year probability of conversion to psychosis was 16%. Higher levels of unusual thought content and suspiciousness, greater decline in social functioning, lower verbal learning and memory performance, slower speed of processing, and younger age at baseline each contributed to individual risk for psychosis. Stressful life events, trauma, and family history of schizophrenia were not significant predictors. The multivariate model achieved a concordance index of 0.71 and, as reported in an article by Carrion et al., published concurrently with this one, was validated in an independent external data set. The results are instantiated in a web-based risk prediction tool envisioned to be most useful in research protocols involving the psychosis prodrome. <br>Conclusions: A risk calculator comparable in accuracy to those for cardiovascular disease and cancer is available to predict individualized conversion risks in newly ascertained clinical high-risk cases. Given that the risk calculator can be validly applied only for patients who screen positive on the Structured Clinical Interview for Psychosis Risk Syndromes, which requires training to administer, its most immediate uses will be in research on psychosis risk factors and in research-driven clinical (prevention) trials.

相关
加载中…
  • Mismatch Negativity and Repetition Positivity Predict Transition to Psychosis in Clinical High Risk Individuals
    Mathalon Daniel H; Hamilton Holly; Bachman Peter; Belger Aysenil; Carrion Ricardo; Duncan Erica; Johannesen Jason; Niznikiewicz Margaret; Cadenhead Kristin18th World Congress of Psychophysiology of the International Organization of Psychophysiology (IOP), 2016-08-31 To 2016-09-04.
  • Effects of the functioning and antipsychotic use on clinical high risk for psychosis: A response to Yung et al.
    Lee, Tae Young; Kim, Sung Nyun; Chon, Myong-Wuk; Kwon, Jun Soo*Schizophrenia Research, 2014, 159(1): 254-255.被引 1
  • Early traumatic experiences, perceived discrimination and conversion to psychosis in those at clinical high risk for psychosis
    Stowkowy Jacqueline*; Liu Lu; Cadenhead Kristin S; Cannon Tyrone D; Cornblatt Barbara A; McGlashan Thomas H; Perkins Diana O; Seidman Larry J; Tsuang Ming T; Walker Elaine F; Woods Scott W; Bearden Carrie E; Mathalon Daniel H; Addington JeanSOCIAL PSYCHIATRY AND PSYCHIATRIC EPIDEMIOLOGY, 2016, 51(4): 497-503.被引 2
查看全部 →

发表信息

论文状态
公开发表
期刊
AMERICAN JOURNAL OF PSYCHIATRY
发表日期
2016-10
卷期
第 173 卷, 第 10 期
页码
980-988
DOI
10.1176/appi.ajp.2016.15070890
语言
ENGLISH
成果收录
SSCI
资助标注
NIH [U01 MH081902, P50 MH066286, U01 MH081857, U01 MH82022, U01 MH 066134, U01 MH081944, R01 U01MH066069, R01 MH076989, U01 MH081928, U01 MH081988]; Genentech; Pfizer; Auspex; Teva

作者

  • C

    Cannon Tyrone D (通讯) (第一作者)

    1 · new

  • Y

    Yu Changhong

查看全部 16 位作者收起作者
  • A

    Addington Jean

  • B

    Bearden Carrie E

  • C

    Cadenhead Kristin S

  • C

    Cornblatt Barbara A

  • H

    Heinssen Robert

  • J

    Jeffries Clark D

  • M

    Mathalon Daniel H

  • M

    McGlashan Thomas H

  • P

    Perkins Diana O

  • S

    Seidman Larry J

  • T

    Tsuang Ming T

  • W

    Walker Elaine F

  • W

    Woods Scott W

  • K

    Kattan Michael W

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417